Five Prime Therapeutics Receives Early HSR Clearance for FPA008 License, Collaboration Agreement With Bristol-Myers Squibb
November 11, 2015 at 04:15 AM EST
Five Prime Therapeutics, Inc. (Nasdaq: FPRX) announced that the Federal Trade Commission has granted early termination of the waiting ...
